Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Four Points By Sheraton Bur Dubai

Dec 12, 2016 8:00 AM - Dec 13, 2016 5:00 PM

Khalid Bin Walid Street, Bur Dubai P.O. Box 33196, Dubai, United Arab Emirates

Practical Guide for Pharmacovigilance: Clinical Trials and Post-Marketing

Pharmacovigilance practices are emerging in the Middle East as the GCC countries are implementing new safety standards based on the European GVP modules. This course is taught by Jan Petracek, former Head of Risk Management at the EMA, with insights on GVP developments and learning any safety professional will benefit from. The course walks you through the essentials of pharmacovigilance practices in pre- and post-marketing phases to enable you hit the ground running when implementing safety reporting. </P>

Faculty

Jan  Petracek, MD, MSc

Jan Petracek, MD, MSc

CEO, Ivigee, Czech Republic

Jan is a passionate and visionary leader in the field of pharmacovigilance, with over 20 years of experience in the industry. He is the CEO of iVigee, a company that provides innovative and sustainable solutions for drug safety and risk management. He is also a Fellow of the International Society of Pharmacovigilance (FISoP), a Global Fellow in Medicines Development (GFMD), and a Qualified Person for Pharmacovigilance (QPPV). Jan has a proven track record of establishing, growing, and selling successful organizations, both for-profit and non-profit, in the pharmacovigilance sector. He has received multiple awards and recognitions, including the DIA Excellence in Service Award in 2018 and HM Queen's Award for International Trade in 2019.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.